Trial Profile
A Pilot Study - Ziprasidone used as an Adjunctive Therapy in patients with Major Depressive Disorder: Impact on Symptoms and Functional Disability
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 23 Feb 2009 New trial record